Presented to you through Paradigm Publishing Services
Princeton University Press
Chapter
Licensed
Unlicensed
Requires Authentication
9. Addressing Exploitation: Reasonable Availability Versus Fair Benefits
You are currently not able to access this content.
You are currently not able to access this content.
Chapters in this book
- Frontmatter i
- Contents vii
- Introduction: Why Exploitation? 1
- 1. Research Ethics, Developing Countries, And Exploitation: A Primer 21
- 2. Case Studies: The Havrix Trial And The Surfaxin Trial 55
- 3. Exploitation in Clinical Research 63
- 4. Testing Our Drugs on the Poor Abroad 105
- 5. Broadly Utilitarian Theories of Exploitation and Multinational Clinical Research 142
- 6. Kantian Ethics, Exploitation, And Multinational Clinical Trials 175
- 7. Exploitation and the Enterprise of Medical Research 206
- 8. Exploitation And Placebo Controls 246
- 9. Addressing Exploitation: Reasonable Availability Versus Fair Benefits 286
- Index 315
Chapters in this book
- Frontmatter i
- Contents vii
- Introduction: Why Exploitation? 1
- 1. Research Ethics, Developing Countries, And Exploitation: A Primer 21
- 2. Case Studies: The Havrix Trial And The Surfaxin Trial 55
- 3. Exploitation in Clinical Research 63
- 4. Testing Our Drugs on the Poor Abroad 105
- 5. Broadly Utilitarian Theories of Exploitation and Multinational Clinical Research 142
- 6. Kantian Ethics, Exploitation, And Multinational Clinical Trials 175
- 7. Exploitation and the Enterprise of Medical Research 206
- 8. Exploitation And Placebo Controls 246
- 9. Addressing Exploitation: Reasonable Availability Versus Fair Benefits 286
- Index 315
